Aptima combo 2, 250 test kit, panther
Ended Purchase Order Awarded Last action
- Contract number
- W91YTZ18P0363
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $873,312
Award facts
- Opportunity
-
- Analyzer and Reagents to test for Chlamydia Trachomatis (CT), Neisseria Gonorrhea and Trichomonas Vaginalis and Human Papilloma Virus (HPV) Solicitation · W91YTZ18Q0261 · Posted Sep 10, 2018
- Contract value 100% obligated
- $873,312.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Campbell, KY 42223, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$74,649 | |
| Funding Only Action | -$34,688 | |
| Funding Only Action | -$129,925 | |
| Funding Only Action | -$90,000 | |
| Funding Only Action | $278,550 | |
| Funding Only Action | -$65,462 | |
| Exercise an Option | $0 | |
| Funding Only Action | $278,550 | |
| Exercise an Option | $0 | |
| Funding Only Action | -$280,837 | |
| Supplemental Agreement for work within scope | $2,988 | |
| Funding Only Action | $275,562 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $314,410 | |
| Change Order | $3,000 | |
| Funding Only Action | $23,125 | |
| Exercise an Option | $0 | |
| Funding Only Action | -$178,437 | |
| Funding Only Action | $275,562 | |
| Exercise an Option | $0 | |
| Funding Only Action | $275,562 | |
| Original award | $0 |
Show all 22
About this award
Gen-Probe Incorporated was awarded a firm fixed price purchase order totaling $873,312.01 by the Defense Health Agency to provide APTIMA COMBO 2, 250 test kits for the detection of Chlamydia Trachomatis and Neisseria Gonorrhea. The tests will be delivered to Fort Campbell, Kentucky by September 30, 2023. The award stems from a September 2018 solicitation requesting quotes for analyzers, reagents, and tests for Chlamydia Trachomatis, Neisseria Gonorrhea, Trichomonas Vaginalis, and Human Papillomavirus. No set-aside designation was applied to this contract awarded to Gen-Probe Incorporated, a medical diagnostics company specializing in molecular testing for infectious diseases. The tests will support medical services at Fort Campbell provided through the Defense Health Agency.
Quick answers
Who was awarded contract W91YTZ18P0363?
W91YTZ18P0363 was awarded to Gen-Probe Incorporated by Medical Command (Department of the Army) on September 24, 2018.
How much is contract W91YTZ18P0363 worth?
The government has obligated $873,312 on W91YTZ18P0363. Its current value, with exercised options, is $873,312.
Which agency awarded contract W91YTZ18P0363?
Medical Command (Department of the Army) awarded W91YTZ18P0363, with funding from Defense Health Agency (Department of Defense).
Was contract W91YTZ18P0363 competed?
The extent of competition for W91YTZ18P0363 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award